Maine Medical Center
Pharmacy residents

PGY1 Pharmacy

The PGY1 Pharmacy Residency program at Maine Medical Center provides the strong foundation needed to become the best pharmacist possible. As both a tertiary care referral center and community hospital, residents are exposed to a broad range of pathology in many sub-specialty areas from a very diverse patient population. Our goal is to develop competent and compassionate pharmacists prepared for their next step whether that be continued training, teaching or patient care.

We have over 40 passionate and motivated preceptors who are trained in the highest levels of their respective fields and are heavily invested in resident’s development. Our small class size allows for strong relationships between residents, faculty and providers in a collegial environment. Our PGY1 residents truly become part of a collaborative interdisciplinary team. Learn more about our faculty.

The PGY1 residency program is a rigorous program that is balanced by the wonderful community that surrounds us in Portland, Maine. Being able to enjoy all that Maine has to offer within a short distance from the hospital allows residents to take a break and recharge. There is no shortage of outdoor activities no matter the season and a vibrant cultural and restaurant scene on par with even the biggest cities without the hassles.

Longitudinal research projects are often structured in a reverse project format. Residents start the year by choosing from a list of projects already approved by the Institutional Review Board (IRB). This approach allows for data collection and analyses to begin right away.

  • Residents receive guidance throughout the process from mentor(s) and Residency Advisory Council – Investigational Team (RAC-IT) members.
  • Residents present a poster at the Vizient Council Meeting and/or the ASHP Midyear Clinical Meeting and Exhibition
  • Residents deliver a platform presentation at the Eastern States Conference for Pharmacy Residents and Preceptors and/or other professional conference
  • Later in the year, residents will work with RAC-IT and/or other team members to bring a new project proposal forward to the IRB; ensuring that the resident receives experience in all facets of research methodology.
  • MMC residents have a successful track record of having their project manuscripts being accepted for publication in a peer reviewed journal.

Below are some examples of recent PGY1 Pharmacy Residency research projects:

  • 2022-2023:
    • Evaluation of a Burn Pain and Sedation Clinical Practice Guideline: A Before-and-After Study
    • Evaluation of Intravenous Immunoglobulin in the Treatment of Severe Hypogammaglobulinemia in Kidney Transplant Recipients to Prevent Hospitalizations Due to Infection
    • Effect of appropriateness of antimicrobial regimens at discharge on global patient outcomes
  • 2021-2022:
    • Medication warning override rates in the EHR by profession and level of training
    • Evaluation of a standardized two-bag protocol for the management of diabetic ketoacidosis in pediatric intensive care unit patient
    • Embedded clinical pharmacist impact on epidiolex lab monitoring requirements
    • Clinical pharmacist real-time review of pediatric discharge prescriptions: can we prevent medication errors?
  • 2020-2021:
    • Bleeding and Thrombotic Complications in Patients with Left Ventricular Assist Devices (LVADs)
    • Penicillin Resistance Among Viridans Group Streptococcal Native Valve Endocarditis
    • Characterization of Treatment and Outcomes in Non-HACEK Gram-Negative Bacilli Endocarditis at an Academic Medical Center
  • 2019-20:
    • Evaluation of a perioperative anticoagulation protocol in renal transplantation: a retrospective analysis
    • A retrospective review of the safety and effectiveness of direct oral anticoagulants (DOACs) in obese patients with atrial arrhythmias who underwent electrical cardioversion
    • Evaluation of a burn pain and sedation clinical practice guideline: the before cohort
    • Evaluation of an institution-specific protocol for hyperglycemic crises management
  • 2018-19:
    • Doxycycline versus vancomycin for cystic fibrosis exacerbations among pediatric patients with MRSA colonization
    • The impact of a clonidine transition protocol on dexmedetomidine withdrawal in critically ill pediatric patients
    • Evaluation of a bivalirudin dosing nomogram for heparin-induced thrombocytopenia
    • Appropriateness of anticoagulation in patients with atrial fibrillation admitted with acute ischemic stroke
    • Assessment of dyskalemia with pentobarbital administration using a monitoring protocol

Our curriculum is developed to provide each resident exposure to a broad range of experiences. Every year our curriculum is customized to the interests and needs of the resident. The program director and preceptors will work with the resident to optimize and adjust the program and learning experiences. Please refer to our manual for more information on learning experiences.


Contact our Program Director
Anne Andrle, MS, PharmD

How to Apply

Learn more about application requirements, stipends & benefits.


Andrle Anne

Learn more about our Program Director, Anne Andrle, MS, PharmD, BCCP